209 related articles for article (PubMed ID: 21691803)
41. The hypoalgesic effect of tramadol in relation to CYP2D6.
Poulsen L; Arendt-Nielsen L; Brøsen K; Sindrup SH
Clin Pharmacol Ther; 1996 Dec; 60(6):636-44. PubMed ID: 8988065
[TBL] [Abstract][Full Text] [Related]
42. Decreased Analgesic Effect of Tramadol in Japanese Patients with CYP2D6 Intermediate Metabolizers after Orthopedic Surgery.
Kamiya T; Hira D; Nakajima R; Shinoda K; Motomochi A; Morikochi A; Ikeda Y; Isono T; Akabane M; Ueshima S; Kakumoto M; Imai S; Morita SY; Terada T
Biol Pharm Bull; 2023; 46(7):907-913. PubMed ID: 37394642
[TBL] [Abstract][Full Text] [Related]
43. CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response.
Slanar O; Nobilis M; Kvetina J; Idle JR; Perlík F
Eur J Clin Pharmacol; 2006 Jan; 62(1):75-6; author reply 77-8. PubMed ID: 16283276
[No Abstract] [Full Text] [Related]
44. Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.
Pedersen RS; Damkier P; Brøsen K
Eur J Clin Pharmacol; 2006 Jul; 62(7):513-21. PubMed ID: 16763825
[TBL] [Abstract][Full Text] [Related]
45. PHARMACOKINETICS OF TRAMADOL HYDROCHLORIDE AND ITS METABOLITE O-DESMETHYLTRAMADOL FOLLOWING A SINGLE, ORALLY ADMINISTERED DOSE IN CALIFORNIA SEA LIONS (ZALOPHUS CALIFORNIANUS).
Boonstra JL; Barbosa L; Van Bonn WG; Johnson SP; Gulland FM; Cox SK; Martin-Jimenez T
J Zoo Wildl Med; 2015 Sep; 46(3):476-81. PubMed ID: 26352950
[TBL] [Abstract][Full Text] [Related]
46. Trends in Tramadol: Pharmacology, Metabolism, and Misuse.
Miotto K; Cho AK; Khalil MA; Blanco K; Sasaki JD; Rawson R
Anesth Analg; 2017 Jan; 124(1):44-51. PubMed ID: 27861439
[TBL] [Abstract][Full Text] [Related]
47. The analgesic effect of tramadol after intravenous injection in healthy volunteers in relation to CYP2D6.
Enggaard TP; Poulsen L; Arendt-Nielsen L; Brøsen K; Ossig J; Sindrup SH
Anesth Analg; 2006 Jan; 102(1):146-50. PubMed ID: 16368820
[TBL] [Abstract][Full Text] [Related]
48. Refractory shock and asystole related to tramadol overdose.
Daubin C; Quentin C; Goullé JP; Guillotin D; Lehoux P; Lepage O; Charbonneau P
Clin Toxicol (Phila); 2007 Dec; 45(8):961-4. PubMed ID: 17852155
[TBL] [Abstract][Full Text] [Related]
49. Covariates of tramadol disposition in the first months of life.
Allegaert K; van den Anker JN; de Hoon JN; van Schaik RH; Debeer A; Tibboel D; Naulaers G; Anderson BJ
Br J Anaesth; 2008 Apr; 100(4):525-32. PubMed ID: 18303070
[TBL] [Abstract][Full Text] [Related]
50. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol.
Tzvetkov MV; Saadatmand AR; Lötsch J; Tegeder I; Stingl JC; Brockmöller J
Clin Pharmacol Ther; 2011 Jul; 90(1):143-50. PubMed ID: 21562485
[TBL] [Abstract][Full Text] [Related]
51. Quantification of drugs in plasma without primary reference standards by liquid chromatography-chemiluminescence nitrogen detection: application to tramadol metabolite ratios.
Ojanperä S; Rasanen I; Sistonen J; Pelander A; Vuori E; Ojanperä I
Ther Drug Monit; 2007 Aug; 29(4):423-8. PubMed ID: 17667796
[TBL] [Abstract][Full Text] [Related]
52. Marked and prolonged serotonin toxicity in a tramadol-poisoned patient with a pharmacokinetic study.
Bianconi G; Malissin I; Labat L; Khoudour N; Houzé P; Pallet N; Mégarbane B; Declèves X
Clin Toxicol (Phila); 2022 Mar; 60(3):382-385. PubMed ID: 34287102
[TBL] [Abstract][Full Text] [Related]
53. Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid.
Yu H; Hong S; Jeong CH; Bae JW; Lee S
Arch Pharm Res; 2018 Mar; 41(3):288-298. PubMed ID: 29196917
[TBL] [Abstract][Full Text] [Related]
54. CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.
Haufroid V; Hantson P
Clin Toxicol (Phila); 2015 Jul; 53(6):501-10. PubMed ID: 25998998
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetics of tramadol and its primary metabolite O-desmethyltramadol in African penguins (Spheniscus demersus).
Kilburn JJ; Cox SK; Kottyan J; Wack AN; Bronson E
J Zoo Wildl Med; 2014 Mar; 45(1):93-9. PubMed ID: 24712167
[TBL] [Abstract][Full Text] [Related]
57. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone.
Samer CF; Daali Y; Wagner M; Hopfgartner G; Eap CB; Rebsamen MC; Rossier MF; Hochstrasser D; Dayer P; Desmeules JA
Br J Pharmacol; 2010 Jun; 160(4):907-18. PubMed ID: 20590587
[TBL] [Abstract][Full Text] [Related]
58. [Pharmacology of tramadol].
Dayer P; Desmeules J; Collart L
Drugs; 1997; 53 Suppl 2():18-24. PubMed ID: 9190321
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism?
Løvlie R; Daly AK; Matre GE; Molven A; Steen VM
Pharmacogenetics; 2001 Feb; 11(1):45-55. PubMed ID: 11207030
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of tramadol hydrochloride and its metabolite O-desmethyltramadol in peafowl (Pavo cristatus).
Black PA; Cox SK; Macek M; Tieber A; Junge RE
J Zoo Wildl Med; 2010 Dec; 41(4):671-6. PubMed ID: 21370649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]